Laboratory Medicine ›› 2017, Vol. 32 ›› Issue (2): 118-121.DOI: 10.3969/j.issn.1673-8640.2017.02.011
• Orginal Article • Previous Articles Next Articles
Received:
2015-11-24
Online:
2017-03-30
Published:
2017-03-30
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2017.02.011
[1] | .田欣,李筱梅,赵敏,等. 颗粒性急性淋巴细胞白血病误诊为急性嗜碱粒细胞白血病一例[J]. 中华检验医学杂志,2011,34(5):467-468. |
[2] | .STEIN P,PEIPER S,BUTLER D,et al.Granular acute lymphoblastic leukemia[J]. Am J Clin Pathol,1983,79(4):426-430. |
[3] | .王立维,高广智,张继红. 颗粒性急性淋巴细胞白血病实验室检查与分析[J]. 实用检验医师杂志,2011,3(1):31-33. |
[4] | .JUNEJA H S,RAJARAMAN S,ALPERIN J B,et al.Auer rod-like inclusions in prolymphocytic leukemia[J]. Acta Haematol,1987,77(2):115-119. |
[5] | .沈元元,翟志敏,李庆,等. 急性混合细胞白血病38例临床研究[J]. 白血病·淋巴瘤,2008,17(5):361-363. |
[6] | .黄静沁,许闪闪,李智,等. 白血病诊断综合分析的重要意义[J]. 检验医学,2014,29(11):1158-1163. |
[7] | .范立权,陈伟琴,王剑飚,等. 12例急性双系列白血病细胞形态学与免疫表型分析[J]. 检验医学,2015,30(5):446-449. |
[1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
[2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
[3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
[4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
[5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
[6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
[7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
[8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
[9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
[10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
[11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
[12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
[13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
[14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
[15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||